Relapse markers in multiple sclerosis: are in vitro cytokine production changes reflected by circulatory T-cell phenotype alterations?

Abstract

In vitro tumor necrosis factor-a (TNF-a), interferon-g (IFN-g) and interleukin-2 (IL-2) production, serum neopterin levels, and T-lymphocyte subpopulations were determined on a monthly basis in 22 MS patients. We found increased in vitro TNF-a production from 4 weeks on prior to the day of an exacerbation. There was a significant correlation with in vitro IFN-g release, the absolute blood monocyte count and the serum neopterin levels, suggesting that monocytes stimulated by IFN-g play an important role in the TNF-a production. Serial analysis of in vitro TNF-a production proved to be a helpful tool in predicting relapses in MS patients. Furthermore, elevated levels of IFN-g and IL-2 after stimulation with OKT3 during exacerbations were demonstrated. These increases were not reflected by changes in T-lymphocyte subpopulations. However, significant differences in T-cell subsets were observed between controls and relapsing progressive patients.

Keywords

multiple sclerosis interferon-γ tumor necrosis factor-α interleukin-2 neopterin T-lymphocyte subpopulations

Get full access to this article

View all access options for this article.

References

PhilippéJ et al. (1996) In vitro TNF-a, IL-2 and IFN-g production as markers of relapses in multiple sclerosis . Clin Neurol Neurosurg 98: 286-290 .

Martin R , McFarland HF , McFarlin DE. (1992) Immunological aspects of demyelinating diseases . Annu Rev Immunol 10: 153-187 .

Panitch HS , Bever CTJ , Katz E , Johnson KP. (1991) Upper respiratory infections trigger attacks of multiple sclerosis in patients treated with interferon-b . J Neuroimmunol 35 (Suppl. 1): 125-125 (abstract).

Sibley WA , Bamford CR , Clark K. (1985) Clinical viral infections and multiple sclerosis . Lancet i: 1313-1315 .

Yednock TA et al. (1992) Prevention of experimental auto-immune encephalomyelitis by antibodies against a4b1 integrin . Nature 356: 63-66 .

Haahr S , Moller-Larsen A , Justesen J , Petersen E. (1986) Interferon induction, 2'-5' oligo A synthetase and lymphocyte subpopulations in out-patients with multiple sclerosis in a longitudinal study . Acta Neurol Scand 73: 345-351 .

Beck J et al. (1988) Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: Do cytokines trigger off exacerbations? Acta Neurol Scand 78: 318-323 .

Chofflon M et al. (1992) Tumor necrosis factor a production as a possible predictor of relapse in patients with multiple sclerosis . Eur Cytokine Netw 3: 523-531 .

Probert L et al. (1995) Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor a . Proc Natl Acad Sci 92: 11294-11298 .

10.

Shoedon G , Troppmair F , Adolf G , Huber C , Niederwieser A. (1986) Interferon-gamma enhances biosynthesis of neopterins in peripheral blood mononuclear cells by induction of GTP-cyclohydrolase I activity . JInterferon Res 6: 697-703 .

11.

Ott M , Demisch L , Engelhardt W , Fischer P-A. (1993) Interleukin-2, soluble interleukin-2 receptor, neopterin, L-tryptophan and b2-microglobulin levels in CSF and serum of patients with relapsing-remitting or chronic-progressive multiple sclerosis . JNeurol 241: 108-114 .

12.

Poser CM et al. (1983) New diagnostic criteria for Multiple Sclerosis: guidelines for research protocols . Ann Neurol 13: 227-231 .

13.

Kurtzke J. (1983) Rating neurological impairment in MS: an Expanded Disability Status Scale (EDSS) . Neurology 33: 1444-1452 .

14.

Rieckmann P et al. (1995) Tumor necrosis factor-alpha messenger expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity . Ann Neurol 37: 82-88 .

15.

Harris JO. (1991) Serial gadolinium-enhanced magnetic resonance imaging scans in patients with early relapsingremitting multiple sclerosis: implications for clinical trials and natural history . Ann Neurol 29: 548-555 .

16.

Olsson T. (1994) Role of cytokines in multiple sclerosis and experimental autoimmune encephalomyelitis . Eur J Neurol 1: 7-19 .

17.

Rieckmann P et al. (1994) Serial analysis of circulating adhesion molecules and TNF receptor in serum from patients with multiple sclerosis: cICAM-1 is an indicator for relapse . Neurology 44: 2367-2372 .

18.

Zaffaroni M et al. (1990) Decrease of CD4+CD45+ T-cells in chronic-progressive multiple sclerosis . JNeurol 237: 1-4 .

19.

Eoli M et al. (1993) Presence of T-cell subset abnormalities in newly diagnosed cases of multiple sclerosis and relationship with short-term clinical activity . JNeurol 240: 79-82 .

20.

Kronfol Z , Turner R , House JD , Winokur G. (1986) Elevated blood neutrophil concentration in mania . JClin Pyschiatry 47: 63-67 .

21.

Podikoglou DG , Lianou PE , Tsankanikas CD , Papavassiliou JT. (1994) Polymorphonuclear leukocyte functions and multiple sclerosis . Neurology 44: 129-132 .